FT-IR (KBr, ʋ cm-1): 3064, 2944, 2842, 2727, 1666, 1612, 1562, 1507, 1447, 1343, 1309, 1094, 768; 1H NMR
(300 MHz, CDCl3): δ (ppm) 3.80 (s, 3H, OMe), 6.05 (s, 1H, CH), 6.84-8.05 (m, 12H, ArH), 11.34 (s, 1H, OH),
11.52 (s, 1H, OH); 13C NMR (75 MHz, CDCl3): δ (ppm) 33.37, 110.93, 116.5, 116.7, 120.4, 123.5, 124.3, 124.7,
128.2, 128.4, 132.44, 152.13, 157.56, 163.7, 165.2.
3,3'-(2-Methoxyphenylmethylene)-bis(4-hydroxy-2H-chromen-2-one) (3g)
FT-IR (KBr, ʋ cm-1): 3412, 3069, 2981, 2724, 1654, 1620, 1550, 1494, 1448, 1337, 1305, 1094, 758; 1H NMR
(300 MHz, CDCl3): δ (ppm) 3.5 (s, 3H, OMe), 6.09 (s, 1H, CH), 6.85-8.04 (m, 12H, ArH), 11.22 (bs, 2H, OH); 13C
NMR (75 MHz, CDCl3): δ (ppm) 35.48, 104.18, 105.74, 113.98, 116.62, 116.89, 124.36, 124.86, 126.90,
127.61, 132.83, 152.25, 152.47, 164.51, 165.69, 169.25.
3,3'-(p-Tolylmethylene)-bis(4-hydroxy-2H-chromen-2-one) (3h)
FT-IR (KBr, ʋ cm-1): 3100, 2992, 2919, 1665, 1614, 1563, 1502, 1440, 1094, 765; 1H NMR (300 MHz, CDCl3): δ
(ppm) 2.34 (s, 3H, CH3), 6.07 (s, 1H, CH), 7.12-8.04 (m, 12H, ArH), 11.34 (s, 1H, OH), 11.48 (s, 1H, OH); 13C
NMR (75 MHz, CDCl3): δ (ppm) 20.97, 35.87, 116.61, 116.93, 124.37, 124.84, 126.36, 129.33, 132.77,
136.46, 152.47, 162.34, 164.5, 165.67.
3,3'-(4-Hydroxyphenylmethylene)-bis(4-hydroxy-2H-chromen-2-one) (3i)
FT-IR (KBr, ʋ cm-1): 3361, 3072, 2731, 1660, 1614, 1565, 1509, 1443, 1096, 762; 1H NMR (300 MHz, CDCl3): δ
(ppm) 6.02 (s, 1H, CH), 6.77-8.02 (m, 12H, ArH), 11.48 (bs, 2H, OH); 13C NMR (75 MHz, CDCl3): δ (ppm)
35.49, 104.16, 115.64, 116.61, 124.37, 126.78, 127.75, 152.41, 154.66, 162.32.
3,3'-(4-Nitrophenylmethylene)-bis(4-hydroxy-2H-chromen-2-one) (3j)
FT-IR (KBr, ʋ cm-1): 3427, 3075, 2935, 1652, 1562, 1343, 1095, 762; 1H NMR (300 MHz, CDCl3): δ (ppm) 6.14
(s, 1H, CH), 7.27-8.17 (m, 12H, ArH), 11.39 (s, 1H, OH), 11.58 (s, 1H, OH); 13C NMR (75 MHz, CDCl3): δ (ppm)
36.18, 103.22, 104.62, 116.26, 116.73, 121.76, 122.12, 124.5, 125.17, 129.59, 132.7, 133.33, 137.9, 148.75,
152.35, 162.34, 166.59, 166.9.
3,3'-(2-Nitrophenyl)methylene)-bis(4-hydroxy-2H-chromen-2-one) (3k)
1
FT-IR (KBr, ʋ cm-1): 3433, 3076, 2722, 1652, 1618, 1561, 1532, 1450, 1352, 1309, 1099, 761; H NMR (300
MHz, CDCl3): δ (ppm) 6.64 (s, 1H, CH), 7.27-8.01 (m, 12H, ArH), 11.55 (bs, 2H, OH); 13C NMR (75 MHz, CDCl3):
δ (ppm) 33.86, 103.71, 116.66, 124.57, 125.03, 128.19, 129.49, 131.9, 133.2, 149.76.
3,3'-(4-Pyridylmethylene)-bis(4-hydroxy-2H-chromen-2-one) (3l)
FT-IR (KBr, ʋ cm-1): 3447, 3075, 2880, 1663, 1618, 1543, 1500, 1407, 1102, 757; 1H NMR (300 MHz, DMSO-
d6): δ (ppm) 6.47 (s, 1H, CH), 7.21-8.68 (m, 12H, ArH and pyridy-H). It is notable that, due deuterium
exchange, hydrogen of two OH groups at region of δ = 11.5 ppm was not observed. 13C NMR (75 MHz,
DMSO-d6): δ (ppm) 38.26, 101.88, 116.20, 119.82, 123.65, 124.67, 125.67, 132.04, 141.35, 153.15, 164.53,
165.34, 168.59.
3. Results and discussion
3.1 Synthesis and characterizations of micro/meso porous acid-activated montmorillonite K10 (H+-Mont)
The study was primarily started by the preparation of H+-Mont clay nanocatalyst in a three-step procedure
(Figure 2): i) preparation of swelled (hydrated) montmorillonite via vigorous stirring of montmorillonite K10
in distilled water. In similar to other clay minerals, montmorillonite K10 can absorb water in its interlayer
spaces. Through the water adsorption, the layers move apart from together giving the swelled
montmorillonite. The swelling expands the surface area of montmorillonite and exposes the cations of
interlayers to contribute in Brønsted and Lewis acid properties of the clay mineral [20], ii) preparation of
homoionic Na+-exchanged montmorillonite by an adequate stirring of the swelled montmorillonite in an